Keyphrases
Mouth Occlusion Pressure
33%
Ventilatory Parameters
33%
Critical Care Management
33%
Potential Bias
33%
Premature Discontinuation
33%
Functional Exercise Capacity
33%
Aerosolized Surfactant
33%
Remdesivir
33%
Exam Performance
33%
Interventional Pulmonology
33%
Acute Exacerbation of COPD (AECOPD)
33%
Respiratory Care Protocols
33%
Convalescent Plasma
33%
Pulmonary Rehabilitation
33%
Severity Assessment
33%
Respiratory Care
33%
Critical Care Medicine
33%
House Officers
33%
Respiratory Therapy
33%
Curricular Milestones
33%
Entrustable Professional Activities
33%
Pulmonary Care
33%
Ebola Virus Disease
33%
United States
33%
West Africa
22%
Nose Clip
16%
Cleveland Clinic
16%
Mechanical Ventilation
11%
Ebola Outbreak
11%
Prospective Clinical Trial
11%
Area-based
11%
Prognosticate
11%
First Assessments
11%
Agonist Treatment
11%
Accessory Respiratory muscles
11%
Arterial Blood Gas Analysis
11%
Sputum Purulence
11%
Critical Illness
11%
Single-payer
11%
Clinical Management
11%
Therapy Intensity
11%
Exacerbation Severity
11%
Triage
11%
Experimental Drugs
11%
Healthcare Economics
11%
COPD Severity
11%
Long-term Sequelae
11%
Supportive Care
11%
CARE Measure
11%
Investigational Drugs
11%
Medicine and Dentistry
Respiratory Care
100%
Intensive Care Medicine
66%
Respiratory Medicine
41%
Ebolavirus
33%
Chronic Bronchitis
33%
Randomized Controlled Trial
33%
Sign Test
33%
Pulmonary Rehabilitation
33%
Virus Infection
33%
Mouth
33%
Health Care Economics
33%
Student T Test
33%
Surfactant
33%
Effect Size
33%
Sputum
20%
Program Director
16%
Breathing
12%
Lung Function
12%
Respiratory Acidosis
11%
Arterial Blood Gas Analysis
11%
Internal Medicine
10%
Scanning Electron Microscopy
8%
Clinical Trial
8%
Clinical Management
8%
Artificial Respiration
8%
Secretion (Process)
8%
Critical Illness
8%
Cilium
8%
Experimental Drug
8%
Supportive Care
8%
Epidemic
8%
Multiple Organ Dysfunction Syndrome
8%
Experimental Therapy
8%
Sequela
8%
Renal Replacement Therapy
8%
Forced Expiratory Volume
8%
Placebo
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Bronchitis
66%
Placebo
41%
Clinical Trial
41%
Prematurity
33%
Ebola Virus Disease
33%
Remdesivir
33%
Surfactant
33%
Lung Alveolitis
33%
Randomized Controlled Trial
33%
Chronic Obstructive Lung Disease
33%
Drug Screening
16%
Anura
11%
Mucolytic Agent
11%
Respiratory Acidosis
11%
Coughing
11%
Critical Illness
8%
Epidemic
8%
Replacement Therapy
8%
Multiple Organ Failure
8%
Scanning Electron Microscopy
8%
Complement Component C5a [Dearginine]
6%
Mortality Rate
5%
Disease Exacerbation
5%
